Inflammation  >>  Novaferon (recombinant anti-tumor and anti-virus protein)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novaferon (recombinant anti-tumor and anti-virus protein) / Genova
ChiCTR-TRC-10000984: Randomized double-blinding controlled multicenter trial of Novaferon for Chronic hepatitis B

Completed
1/2
360
 
Novaferon, intramuscular injection ;interferon alpha 2b, intramuscular injection
The XiangYa Hospital, ZhongNan University; Genova Biotech Company, Ltd, National Novel Drug Development plan
Chronic hepatitis B
 
 

Download Options